https://www.selleckchem.com/Androgen-Receptor.html
Aim To provide an assessment of published literature on the demographic representation in Phase I trials of biopharmaceutical oncology agents. Materials methods We conducted a rapid evidence assessment to identify demographic representation reported in Phase I clinical trials for biopharmaceutical oncology agents published in 2019. Results Globally, the population was predominantly White/Caucasian (62.2%). In the USA, the distribution was heavily skewed toward White/Caucasian (84.2%), with minimal representation of Blacks/African
Like
Comment
Share
